Hjem › Hodgkins lymfom › New York
Kliniske studier for Hodgkins lymfom i New York
15 studier for Hodgkins lymfom søker deltakere på steder i New York.
Byer i New York
- New York City11 studier
- Greenburgh5 studier
- Queens4 studier
- Staten Island3 studier
- New Rochelle3 studier
Offisiell studietekst (engelsk)
Phase II Study of Second- Line Pembrolizumab Plus GVD for Relapsed or Refractory Hodgkin Lymphoma
- Memorial Sloan Kettering Cancer Center @ Commack, Commack
- Memorial Sloan Kettering Westchester, Harrison
- Memorial Sloan Kettering Cancer Center, New York
- og 1 flere
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 24. sep. 2026 · NCT03618550Safety and Preliminary Efficacy of MT-601 in Patients With Relapsed/Refractory Lymphoma
- Cornell, New York
RekruttererFase 1
Alder 18 til 100 · Alle kjønn · Oppdatert 15. sep. 2026 · NCT05798897AZD3470 as Monotherapy or in Combination With Anticancer Agent(s) in Participants With Haematologic Malignancies.
- Research Site, New York
RekruttererFase 1/2
Alder 12 og eldre · Alle kjønn · Oppdatert 14. sep. 2026 · NCT06137144Testing the Combination of Nivolumab and ASTX727 for Relapsed or Refractory B-Cell Lymphoma
- NYU Langone Hospital - Long Island, Mineola
- Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 10. sep. 2026 · NCT05272384A Phase 1 of CTX-8371 in Patients With Advanced Malignancies
- Roswell Park Cancer Institute, Buffalo
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 28. jul. 2026 · NCT06150664Brentuximab Vedotin in Early Stage Hodgkin Lymphoma
- Memorial Sloan Kettering Cancer Center, New York
RekruttererFase 3
Alder 16 til 69 · Alle kjønn · Oppdatert 8. jul. 2026 · NCT04685616A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
- Roswell Park Cancer Institute, Buffalo
- North Shore University Hospital, Lake Sucess
- Cohen Children's Medical Center of New York, New Hyde
- og 9 flere
RekruttererObservasjonsstudie
Alle aldre · Alle kjønn · Oppdatert 6. jul. 2026 · NCT01351545Patient-Reported Outcomes and Quality of Life in Adult and Pediatric Patients With Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)
- Memorial Sloan Kettering Cancer Center, New York
- University of Rochester Medical Center, Rochester
RekruttererObservasjonsstudie
Alder 8 og eldre · Alle kjønn · Oppdatert 20. mai 2026 · NCT06098430Cord Blood Transplantation in Children and Young Adults With Blood Cancer
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
RekruttererFase 2
Opp til 26 år · Alle kjønn · Oppdatert 14. mai 2026 · NCT07566377A Study of BV-AVD in People With Bulky Hodgkin Lymphoma
- Memorial Sloan Kettering Suffolk - Commack (All Protocol Activities), Commack
- Memorial Sloan Kettering Westchester (All Protocol Activities), Harrison
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
- og 1 flere
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 23. apr. 2026 · NCT06377566Autologous Stem Cell Transplant Followed by Polatuzumab Vedotin in Patients With B-cell Non-Hodgkin and Hodgkin Lymphoma
- New York Medical Center, Valhalla
RekruttererFase 1/2
Alder 12 til 70 · Alle kjønn · Oppdatert 15. apr. 2026 · NCT04491370Longitudinal Sexual and Reproductive Health Study of Women With Breast Cancer and Lymphoma
- Memorial Sloan Kettering Commack, Commack
- Memorial Sloan Kettering Westchester, Harrison
- Memorial Sloan Kettering Cancer Center, New York
- og 1 flere
RekruttererObservasjonsstudie
Alder 18 og eldre · Kvinner · Oppdatert 4. mar. 2026 · NCT01788839AlloSCT for Malignant and Non-malignant Hematologic Diseases Utilizing Alpha/Beta T Cell and CD19+ B Cell Depletion
- New York Medical College, Valhalla
RekruttererFase 2
1 Day – 30 Years · Alle kjønn · Oppdatert 8. aug. 2025 · NCT04099966Chemoradiotherapy With Targeted Immunotherapy in Pediatric Lymphoma
- New York Medical College, Vallhala
RekruttererFase 2
Alder 3 til 39 · Alle kjønn · Oppdatert 13. jun. 2025 · NCT05253495Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
- Children's Hospital New York-Presbyterian, New York
- Memorial Sloan Kettering Cancer Center, New York
RekruttererFase 1
Alder 1 til 21 · Alle kjønn · Oppdatert 6. des. 2024 · NCT05476770Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.